Moscow, Russia

Alexander Golubev

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Golubev. Retrieved from https://idiyas.com/inventor/alexander-golubev-updh3npk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexander Golubev: Innovator in Pharmaceutical Intermediates

Introduction

Alexander Golubev is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on chemical compounds.

Latest Patents

Golubev holds a patent for "Bis(trifluoromethyl)hydantoins as intermediates for pharmaceutically active ingredients." This patent highlights his expertise in developing chemical intermediates that are crucial for creating effective pharmaceutical products. He has 1 patent to his name, showcasing his focused contributions to the industry.

Career Highlights

Currently, Alexander Golubev is employed at Aventis Pharma Deutschland GmbH, where he continues to work on advancing pharmaceutical research and development. His role at this prominent company allows him to collaborate with other experts in the field and contribute to innovative solutions in healthcare.

Collaborations

Throughout his career, Golubev has worked alongside esteemed colleagues such as Hans Ulrich Stilz and Klaus Burger. These collaborations have further enriched his research and development efforts, leading to advancements in pharmaceutical sciences.

Conclusion

Alexander Golubev's work in the pharmaceutical industry exemplifies the impact of innovative thinking in developing essential chemical compounds. His contributions continue to influence the field and pave the way for future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…